Chargement en cours...
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
The relevance of PCSK9 in atherosclerosis progression is demonstrated by the benefits observed in patients that have followed PCSK9-targeted therapies. The impact of these therapies is attributed to the plasma lipid-lowering effect induced when LDLR hepatic expression levels are recovered after the...
Enregistré dans:
| Publié dans: | Front Cardiovasc Med |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021767/ https://ncbi.nlm.nih.gov/pubmed/33834043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.639727 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|